Have a personal or library account? Click to login
Impact of twelve weeks march field training on intermittent claudication in patients with peripheral artery disease after endovascular procedures Cover

Impact of twelve weeks march field training on intermittent claudication in patients with peripheral artery disease after endovascular procedures

Open Access
|Apr 2019

Abstract

Introduction

March Training (MT) is one of the ways to improve the results of treatment in patients with peripheral artery disease (PAD). The aim of this study was to investigate the effect of 12 weeks of march training on the claudication distance in patients with PAD who underwent endovascular surgery.

Material and methods

The study included 30 patients with peripheral arterial disease (PAD) and evaluated the claudication distance on a treadmill: before endovascular surgery, 3 days and 3 months after the surgery. The maximum claudication distance (MCD) was measured during each test on a treadmill. Patients were randomly divided into 2 groups of 15: group A consisted of patients who were not recommended to march after endovascular surgery and group B consisted of patients to whom training was recommended. Patients in group B were recommended march training at home for 3 months according to the following schedule: walking at a regular walking pace of 60-120 feet’s per minute for at least 30 minutes, 3 times a day, 3 days a week, supervised by a physiotherapist.

Results

Group A - MCD before surgery: 103,23m, MCD 3 days after surgery: 179m, MCD 3 months after treatment: 136,67m, p <0.001.

Conclusions

MCD carried out for 3 months after endovascular treatment of patients with PAD is better in group of patient systematically doing march training compared to patients without such training.

Language: English
Page range: 15 - 21
Published on: Apr 11, 2019
In partnership with: Paradigm Publishing Services

© 2019 Maciej Waldemar Kostewicz, Waldemar Kostewicz, published by University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.